Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Convergent Ablation Plus Left Atrial Appendage Isolation for the Treatment of Persistent Atrial Fibrillation

NCT06165510 is registered in ClinicalTrials.gov with Barts & The London NHS Trust as lead sponsor.

NCT NCT06165510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06165510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Convergent Ablation Plus Left Atrial Appendage Isolation for the Treatment of Persistent Atrial Fibrillation
Lead sponsor
Barts & The London NHS Trust
Phase
Not applicable
Overall status
Recruiting
Start date
August 2, 2024
Completion date
November 30, 2026
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial arrhythmia, atrial fibrillation, persistent, atrium; fibrillation, persistent atrial fibrillation